Fidelity Investments Portfolio holdings
Fidelity Investments, founded in 1946 by Edward C. Johnson II and headquartered in Boston, Massachusetts, is one of the largest privately-held financial services firms in the world, managing hundreds of billions in assets. Known for its wide array of investment products, including mutual funds, retirement accounts, brokerage services, and wealth management, Fidelity caters to both individual investors and institutions with a reputation for strong customer service and innovative tools like its active trader platforms. The company pioneered direct-to-investor mutual fund sales, bypassing traditional brokers, and has since expanded into areas like cryptocurrency trading and commission-free stock trades. Still family-controlled by the Johnson family, Fidelity blends a legacy of traditional investing with a forward-looking approach to technology and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$1.07B |
| 2 |
Alibaba
BABA
|
+$932M |
| 3 |
AET
Aetna Inc
AET
|
+$825M |
| 4 |
Becton Dickinson
BDX
|
+$822M |
| 5 |
Cognizant
CTSH
|
+$716M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.03B |
| 2 |
NVIDIA
NVDA
|
+$990M |
| 3 |
Apple
AAPL
|
+$983M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$837M |
| 5 |
NXP Semiconductors
NXPI
|
+$760M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.39% |
| 2 | Financials | 16.28% |
| 3 | Healthcare | 14.03% |
| 4 | Communication Services | 10.9% |
| 5 | Consumer Discretionary | 10.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1251
Hess Midstream
HESM
$5.24B
| $54.2M | 0.01% |
+2,661,264
| New | +$63.5M |
|
1252
Cavco Industries
CVCO
$4.22B
| $54M | 0.01% |
416,180
+86,212
| +26% | +$10.3M |
|
1253
iShares Floating Rate Bond ETF
FLOT
$10.2B
| $53.9M | 0.01% |
1,058,461
+52,070
| +5% | +$2.65M |
|
1254
Royal Gold
RGLD
$16.8B
| $53.7M | 0.01% |
687,313
-49,700
| -7% | -$3.74M |
|
1255
First Hawaiian
FHB
$3.38B
| $53.6M | 0.01% |
1,751,392
+1,208,748
| +223% | +$35.3M |
|
|
JNCE
1256
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $53.6M | 0.01% |
3,972,016
-74,300
| -2% | -$1.59M |
|
|
CMD
1257
DELISTED
Cantel Medical Corporation
CMD
| $53.6M | 0.01% |
688,152
+113,942
| +20% | +$8.56M |
|
1258
New Jersey Resources
NJR
$5.84B
| $53.5M | 0.01% |
1,347,550
+75,667
| +6% | +$3.1M |
|
1259
SPS Commerce
SPSC
$2.64B
| $53.5M | 0.01% |
1,677,800
-22,800
| -1% | -$677K |
|
|
JUNO
1260
DELISTED
Juno Therapeutics, Inc.
JUNO
| $53.4M | 0.01% |
1,786,938
-131,654
| -7% | -$3.25M |
|
|
SRCLP
1261
DELISTED
Stericycle, Inc
SRCLP
| $53.3M | 0.01% |
840,940
-180,560
| -18% | -$12.7M |
|
|
SPN
1262
DELISTED
Superior Energy Services, Inc.
SPN
| $53.3M | 0.01% |
510,965
-32,963
| -6% | -$3.84M |
|
1263
Align Technology
ALGN
$12.1B
| $52.9M | 0.01% |
352,469
+94,519
| +37% | +$12.8M |
|
|
TARO
1264
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $52.3M | 0.01% |
466,590
+138,353
| +42% | +$15.6M |
|
1265
Encore Capital Group
ECPG
$2.02B
| $52.1M | 0.01% |
1,298,705
+682,097
| +111% | +$24.5M |
|
1266
AB InBev
BUD
$170B
| $52M | 0.01% |
471,492
-144,712
| -23% | -$16.6M |
|
1267
iShares Currency Hedged MSCI Eurozone ETF
HEZU
$570M
| $52M | 0.01% |
1,772,686
+90,623
| +5% | +$2.69M |
|
1268
State Street SPDR Dow Jones International Real Estate ETF
RWX
$269M
| $51.7M | 0.01% |
1,356,577
-207,615
| -13% | -$8.02M |
|
1269
Intellia Therapeutics
NTLA
$1.49B
| $51.6M | 0.01% |
3,226,832
-774,103
| -19% | -$10.8M |
|
1270
Aclaris Therapeutics
ACRS
$726M
| $51.4M | 0.01% |
1,896,206
+242,269
| +15% | +$6.59M |
|
1271
Archer Daniels Midland
ADM
$38.2B
| $51.4M | 0.01% |
1,242,184
+311,918
| +34% | +$13.4M |
|
|
DF
1272
DELISTED
Dean Foods Company
DF
| $51M | 0.01% |
2,998,781
+1,079,205
| +56% | +$20.2M |
|
|
BOJA
1273
DELISTED
Bojangles', Inc. Common Stock
BOJA
| $50.5M | 0.01% |
3,109,039
+406,647
| +15% | +$7.49M |
|
1274
Rigel Pharmaceuticals
RIGL
$681M
| $50.1M | 0.01% |
1,835,786
+2,212
| +0.1% | +$60.5K |
|
1275
Minerva Neurosciences
NERV
$185M
| $50.1M | 0.01% |
707,599
+85,000
| +14% | +$5.5M |
|
Similar funds
Fidelity Investments's Q2 2017 Portfolio in Review
As of Q2 2017, Fidelity Investments held 2,774 positions worth $805B, up 2.2% from $787B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Fidelity Investments's Q2 2017 filing shows 131 new, 1,094 increased, 1,140 reduced and 163 closed positions. Its largest new stake was DXC Technology: 5,662,450 shares worth $376M. The largest sale was Tesla, an estimated $1.03B.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.
- Fidelity Investments's largest Q2 2017 buy was DXC Technology: 5,662,450 shares worth $376M.
- Fidelity Investments added most to PayPal in Q2 2017, an estimated $1.07B increase.
- Fidelity Investments's biggest Q2 2017 reduction was Tesla, cutting an estimated $1.03B.
- Fidelity Investments fully exited Mead Johnson Nutrition Company in Q2 2017, selling an estimated $479M.
- Fidelity Investments's ten largest holdings make up 17% of its $805B portfolio in Q2 2017.
- Fidelity Investments opened 131 new positions and closed 163 in Q2 2017.
- Fidelity Investments's portfolio value rose 2.2% quarter-over-quarter to $805B.
Based on Fidelity Investments's 13F filing for Q2 2017, filed 11 Aug 2017.